Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06246149
Title Adjuvant Tebentafusp in High Risk Ocular Melanoma (ATOM)
Acronym ATOM
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors European Organisation for Research and Treatment of Cancer - EORTC
Indications
Therapies
Age Groups: senior | adult
Covered Countries POL | FRA | DEU


No variant requirements are available.